H. Müller-Huesmann

INSL3 in the benign hyperplastic and neoplastic human prostate gland

Thomas Klonisch, H. Müller-Huesmann, Maria Riedel et al. · International Journal of Oncology · 2005 · 44 citations

Medicine, Endocrinology, Molecular Biology +10

Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO

Christian Grohé, Thomas Wehler, Tobias Dechow et al. · Translational Lung Cancer Research · 2022 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study

Christian Grohé, Werner J. Blau, Wolfgang Gleiber et al. · Clinical Oncology · 2022 · 17 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA Study

Marc‐Oliver Grimm, Viktor Grünwald, H. Müller-Huesmann et al. · European Urology Focus · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany

Michael P. Lux, C. Minartz, H. Müller-Huesmann et al. · Cancer Treatment and Research Communications · 2022 · 10 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17